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Supplemental Figure 1. Heat maps for RNAseq analysis of gene expression in lung tissue after SeV infection. 
Conditions correspond to Figure 1 (PBS control and 12 and 21 d after SeV infection in WT mice). Gene list is 
based on greatest fold-change (FC) or F-statistic difference from PBS control condition. Basal epithelial cell or 
basal epithelial cell lineage genes of interest to post-viral lung disease are annotated by colors for indicated 
categories. Data represent results from a single experiment with n=3 mice per condition. 
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Supplemental Figure 2. Levels of proliferating Aqp3+Itga6+ basal epithelial cells and Sftpc+ 
AT2 cells after SeV infection. A, Immunostaining for Ki-67 in lung sections from WT mice after 
SeV infection. B, Levels of Sftpc and Il33 mRNA in indicated FACS-isolated cell populations. C, 
Phase-contrast microsopy images of lung spheroids formed from EpCAM+Aqp3+ cells and 
cultured with and without IL-13.  D, Corresponding immunostaining for Muc5ac of lung spheroid 
cells for conditions in (D). E, Levels of lung spheroids and Muc5ac mRNA in spheroids for 
conditions in (D). F, Flow cytograms for Ki-67 in CD31–CD45– cells relative to Aqp3 and Itga6 
expression at 12 d after SeV or SeV-UV. G, Flow cytograms of lung epithelial (CD31–CD45–) 
cells based on Ki-67, EpCAM, Aqp3, and Itga6 expression in wild-type mice at 12 d after SeV or 
SeV-UV. Values indicate % of cells within each gate. H, Flow cytograms of lung epithelial 
(CD31–CD45–EpCAM+) cells based on Aqp3 and Itga6 expression in WT mice after SeV or SeV-
UV. Values indicate % of cells within each gate. Data represent results from a single experiment 
with n=3 mice per condition and were replicated twice. *P<0.05 using ANOVA with Bonferroni 
correction. *P<0.01 using ANOVA with Bonferroni correction.   
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Supplemental Figure 3. Gene expression analysis for scRNAseq of lung epithelial cells after 
SeV infection. A, Heat map for top cluster marker genes for lung epithelial (CD45–CD31–
EPCAM+) cells (n=18,465 single cells) from lungs of WT mice for combined sample conditions 
(12 and 21 d after SeV or PBS). B, Dot-plot of highly expressed marker genes for conditions in 
(A). Data represent results from a single experiment with n=3 mice per condition. 
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Supplemental Figure 4. Basal-ESC lineage restriction to airway (including mucous) cells. A, Immunostaining for Krt5 
and GFP with DAPI counterstaining in lung sections from Krt5-Gfp mice at 49 d after infection with SeV. Yellow arrows, 
double-positive (Krt5+Krt5-GFP+) basal epithelial cells. B, Immunostaining for Krt5 with DAPI counterstaining in cells 
prepared from WT mice using FACS for CD31–CD45–EpCAM+Aqp3– and CD31–CD45–EpCAM+ Aqp3+ lung cells. C, 
Scheme for lineage tracing using Krt5-CreERT2–ROSA26mTmG mice precisely timed for tamoxifen (Tam) treatment and 
SeV infection. D, Immunostaining for GFP and indicated marker (Krt5, Aqp3, Muc5ac, b-Tubulin IV, Scgb1a1, and Sftpc) 
with DAPI counterstaining in lung sections from Krt5-CreERT2–ROSA26mTmG mice. Yellow arrows, double-positive 
(Krt5-GFP+epithelial-marker+) cells; red arrows, single-positive (Krt5-GFP–Marker+) cells. E, Immunostaining for GFP and 
Krt5 or Muc5ac marker with DAPI counterstaining in lung sections imaged with confocal laser scanning microscopy to 
identify Krt5-GFP-trace in Krt5+ and Aqp3+ basal cells and Muc5ac+ mucous cells for conditions in (D). F, Quantification of 
GFP tracing into indicated epithelial cell subset populations using violin plots for conditions in (D). Data represent results 
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Supplemental Figure 5. IL-33-cherry-reporter mice track IL-33 expression to alveolar epithelial type 2 (AT2) cells. A, Flow 
cytograms of lung epithelial (CD31–CD45–) cells based on Aqp3 and EpCAM expression for heterozygous IL-33-cherry reporter (Il33+/–
) mice at 21 d after SeV or SeV-UV. Values indicate % of cells within each gate. B, Numbers of indicated cell populations for conditions 
in (A). C, Aqp3 immunostaining of lung sections from Il33+/– mice at 21 d after SeV or SeV-UV. D-G, Lung levels of mRNA markers 
for basal cells (D), IL-33+ cells (E), type 2 immune response (F), and mucus production (G) for Il33+/– mice at 49 d after SeV infection 
or SeV-UV. H, Immunostaining for Muc5ac in lung sections from WT, Il33–/–, and Il33+/– mice at 49 d after SeV or SeV-UV. I, 
Immunofluorescence for cherry-reporter and immunostaining for Sftpc, Krt5, Scgb1a1, and Aqp3 in lung sections from Il33+/– mice at 
21 d after SeV or SeV-UV. J, Using Il33+/– mice crossed to Sftpc+/gfp mice (Il33+/––Sftpc+/gfp) and WT mice, flow cytograms for cherry 
and GFP reporter fluorescence from lung epithelial (CD31–CD45–EpCAM+) cells from WT and Il33+/––Sftpc-gfp mice at 21 d after SeV 
or SeV-UV and for corresponding cherry-reporter fluorescence and Aqp3 staining. K, Levels of Il33 and Il13 mRNA in lung tissue from 
WT mice at 0-49 d after SeV. L, Levels of IL-33 and IL-13 protein in lung tissue and BAL fluid for conditions in (K). Data represent 
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Supplemental Figure 6. Gene expression analysis for scRNAseq of lung epithelial cells and cell-
cycle activation. A, Gene-gene plots for expression of cell-cycle proliferation and survival genes within 
and across cell clusters 3 and 9 in lungs of WT versus Il33–/– mice for combined sample conditions. B, 
t-SNE plots for expression of selected cell-cycle genes (Cdk1, Pclaf, Dapl1, Psca) for each sample 
condition in WT mice.  C, Corresponding violin plots for expression of selected cell cycle genes for 
combined sample conditions from (B). Data represent results from a single experiment with n=3 mice 
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Supplemental Figure 7. Single-cell chromatin accessibility linked to IL33 expression in a basal-ESC subset. A, t-SNE plot for 
scATACseq analysis of lung epithelial (CD31–CD45– EpCAM+) cells from WT and Il33–/– mice at 12 d after SeV infection. B, t-
SNE plot for cell clusters in (a) mapped on to gene clusters identified from scRNAseq analysis at 12 d after SeV infection. C, 
Integrated genomic view (IGV) analysis for peaks of activity for the Il33 gene for the individual cell clusters identified from (A) at 
12 d after SeV infection. Orange-line box designates AT2 cells (clusters 6, 13, 16, 19) with unchanged signal in Il33–/– compared to 
WT mice; red-line box designates basal cells and basal-cell lineage cells (cluster 20) with a decreased signal in Il33–/– compared to 
WT mice. Red boxes indicate gene-promoters near the transcription start site with an associated STAT3-transcription factor binding 
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Supplemental Figure 8. Effect of Il33 and Il1rl1 gene expression on ESC proliferation after viral infection. A, Flow 
cytograms for Ki-67 levels in lung epithelial (CD31–CD45–EpCAM+) cells (Aqp3– and Aqp3+ subsets) in Il33–/–, and 
Il1rl1–/– mice at 12 d after SeV infection or SeV-UV. (WT data reproduced from Figure 2H). B, Flow cytograms of lung 
epithelial (CD31–CD45–) cells based on EpCAM and Aqp3 expression in WT, Il33–/–, and Il1rl1–/– mice at 12 and 21 d 
after SeV infection or SeV-UV. Values indicate % of cells within each gate. C, Levels of lung spheroid formation from 
Aqp3+ lung epithelial (CD31–CD45– EpCAM+) cells isolated from WT and Il33–/– mice at 21 d after SeV infection and 
then 3D-cultured with and without treatment with IL-33 (10 ng/ml for 10 d). D, Levels of Il1rl1 mRNA in ILC2 (SSlowlin–
CD90.2+ST2+) and epithelial cells (CD31–CD45–EpCAM+) that were isolated by FACS from lung tissue of WT mice at 
49 d after SeV or SeV-UV. E, Flow cytometry histograms for IL-33R (ST2) levels on indicated epithelial cell populations 
after SeV or SeV-UV. F, Immunostaining for Sftpc in lungs sections at 49 d after SeV infection for conditions in (A). 
Data represent results from a single experiment with n=3 mice per condition and were replicated twice. *P<0.05 using 
ANOVA with Bonferroni correction. 
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Supplemental Figure 9. IL-33 versus ST2 requirement for gene expression, remodeling, and functional readouts for 
PVLD. A-D, Lung levels of mRNA markers for basal cells (A), AT2 cells (B), type 2 immune response (C), and mucus 
production (D) for WT and Il33–/– mice at 49 d after SeV versus SeV-UV. E-H, Corresponding lung levels of mRNA markers 
for WT and Il1rl1–/– mice for conditions in (A-D). I, PAS and hematoxylin staining of lung sections for WT, Il33–/–, and 
Il1rl1–/– mice at 49 d after SeV or SeV-UV. J, Quantitation for conditions in (I). K, Immunostaining for Aqp3 and Pdpn in 
lung sections from Il33–/– and Il1rl1–/– mice at 49 d after SeV or SeV-UV. L, Immunostaining for Sftpc and Pdpn for 
conditions in (K). M, Respiratory system resistance (RRS) at baseline for WT and Il33–/– mice at 49 d after SeV or SeV-UV. 
N, Corresponding RRS at baseline and after inhaled methacholine (MCh) for conditions in (M). Data represent results from a 
single experiment with n=5 mice per condition and were replicated twice. *P<0.05 using ANOVA with Bonferroni correction. 
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Supplemental Figure 10. Conditional deletion of Il33 reveals selective control of basal epithelial cells. A, Design scheme 
for mouse Il33-floxed allele using CRISPR/Cas9-mediated modification of the Il33 gene. B, Validation of heterozygous 
Il33+/flox (+/f) and WT (+/+) mice based on BamH I digestion, PCR-based amplification, and agarose gel electrophoresis. C, 
Protocol scheme for analysis of Krt5-Cre-Ert2–Il33flox/flox and Krt5-Cre-Ert2–ROSA-DTA mice with tamoxifen (Tam) 
treatment. D, Immunostaining for Krt5 and IL-33 with DAPI counterstaining of skin, esophagus, and trachea from Krt5-Cre-
Ert2–Il33flox/flox, Il33–/–, and Krt5-Cre-Ert2–ROSA-DTA mice at 10 weeks of age as diagrammed in (C). E, Hematoxylin and 
eosin staining for conditions in (D). Data represent results from a single experiment with n=5 mice per condition and were 
replicated twice. *P<0.05 using ANOVA with Bonferroni correction.  
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Methods 
Mouse line generation and treatment. Wild-type C57BL/6J mice (000664) were obtained from Jackson Laboratories (Bar 
Harbor, ME). The Il33-cherry reporter mice were generated in the C57BL/6J strain with insertion of an mCherry-reporter 
cassette as described recently (1). The Il1r11–/– mice (2, 3) were obtained from Paul Bryce (Northwestern University, Chicago, 
IL). The Sftpc-gfp reporter mice (4) and Krt5-gfp mice (5) were obtained from Scott Randell (University of North Carolina, 
Chapel Hill, NC). The Krt5-CreERT2 mice (6) backcrossed to C57BL/6N mice (#029155) and ROSA26mTmG reporter mice 
(#007676) were obtained from Jackson Laboratories and crossed to generate Krt5-Cre-Ert2–ROSA26mTmG mice. The 
Il33flox/flox mice were generated in C57BL/6J mice with LoxP sites inserted before and after exon 1 and crossed to Krt5-Cre-
Ert2 mice to generate Krt5-Cre-Ert2–Il33flox/flox mice (Supplemental Figure 10A,B). The ROSA-DTA mice (7) were obtained 
from Jackson Laboratories (#009669) and crossed with Krt5-Cre-ERT2 mice to generate heterozygous Krt5-Cre-Ert2–ROSA-
DTA mice. Mice were inoculated intranasally with Sendai virus (SeV strain 52) or an equivalent amount of UV-inactivated 
virus (SeV-UV) or PBS as controls as described previously (8, 9). For lineage tracing and conditional Il33 gene deletion 
experiments, Krt5-Cre-Ert2–ROSA26mTmG and Krt5-Cre-Ert2–Il33flox/flox mice were treated with or without tamoxifen (0.25 
mg/g of body weight given intraperitoneally every other day for 3 doses at 21-25 d before SeV infection) as described 
previously (10). All mice were maintained on a C57BL/6J background and were co-housed in a barrier facility using cages 
fitted with micro-isolator lids. Male mice at 5-6 weeks of age were used to minimize variability in response to infection, 
although male and female mice respond similarly as reported previously (8, 11, 12).  
RNAseq analysis. Lung tissue RNA was purified as described previously (13) from three mice per sample condition (12 or 
21 d after SeV infection or PBS control challenge) and subjected to RNAseq using a NovaSeq 6000 with S4 flow cell 
(Illumina, San Diego, CA) in the Genome Technology Access Center in the McDonnell Genome Institute (Washington 
University, St. Louis). For RNAseq analysis, gene and transcript levels were quantified using the RSEM (version 1.3.2; 
https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-12-323) pipeline, and the estimated counts were 
stored as the appropriate raw data to feed into the edgeR (version 3.24.3; 
https://bioconductor.org/packages/release/bioc/html/edgeR.html), limma (version 3.38.3; 
https://www.ncbi.nlm.nih.gov/pubmed/25605792; 
https://www.bioconductor.org/packages/release/bioc/vignettes/limma/inst/doc/usersguide.pdf), and voom (version 3.38.3; 
https://www.ncbi.nlm.nih.gov/pubmed/24485249) pipeline. The list of Ensemble gene ids was annotated by the biomaRt 
(version 2.38.0), which queried BioMart databases 
(https://bioconductor.org/packages/release/bioc/vignettes/biomaRt/inst/doc/biomaRt.html) to retrieve additional information 
including entrezgene identifiers for gene symbol and chromosome. A DGEList appropriate for our data was declared, and 
filterByExpr function in edgeR was used to maintain 35% of the genes in the gene list by filtering out lowly expressed genes 
automatically and in a principled way. The data were then normalized to account for variability in sequencing depth, library 
size (https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191629), and other external factors that are not of 
biological interest. After TMM normalization, unsupervised heirarchical clustering with the hclust function in base R (version 
3.5.3) and principal component analysis with the prcomp function were conducted to identified treatment and control clusters. 
The correlations between replicate samples were also examined, with the lowest value of 0.94. We invoked voom software 
to compute precision weights and fitted linear models to the data using the lmFit function. Then, we refitted the model using 
the contrasts.fit function and computed moderated t- and F-statistics using the eBayes and treat functions, respectively. We 
chose the outputs from treat function for a more stringent definition of statistical significance to test against a fold change 
threshold. Two heatmaps were generated with heatmap.2 function in gplots (version 3.1.0), based on subsets of the top 100 
most significant genes sorted separately by the F-statistic and fold change. We also generated scatter plots with ggplot2 
(version 3.3.2) with the top genes ranked by fold change labelled of our interest.  
Real-time qPCR assay. RNA was purified from lung homogenates or cellular lysates using Trizol (Invitrogen) and was 
converted to cDNA using a High-Capacity cDNA Archive kit (Applied Biosystems). Target mRNA was quantified by real-
time PCR assay using specific fluorogenic probes and primer sets and the Fast Universal PCR Master Mix system (Applied 
Biosystems). Primer-probe sets for viral RNA and mouse mRNA targets are listed in (Supplemental Table 2). All probes 
were designed to span introns and did not react with genomic DNA. Samples were assayed with the 7300HT or QuantStudio 
6 Flex Fast Real-Time PCR System and analyzed using Fast System Software (Applied Biosystems). Cycle threshold (Ct) 
values were normalized to GAPDH mRNA level and then expressed as fold-change (FC) relative to the mean Ct value for 
control samples using the delta-delta Ct method (14).  
Immunohistochemistry and immunocytochemistry. Tissues were fixed with 10% formalin, embedded in paraffin, cut into 
5-µm sections, and adhered to charged slides. Sections were deparaffinized in Fisherbrand® CitroSolv® (Fisher), hydrated, 
and treated with heat-activated antigen unmasking solution (Vector Laboratories, Inc). Immunostaining was performed using 
primary antibodies (Supplemental Table 1) followed by secondary antibodies directly conjugated to Alexa Fluor 488 nm or 
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594 nm fluorochromes (Invitrogen) for immunofluorescence microscopy. All sections were counterstained with DAPI and 
were imaged using a Leica DM5000 B microscope for conventional imaging. Staining was quantified in whole lung sections 
using a NanoZoomer S60 slide scanner (Hamamatsu) and ImageJ software as described previously (9, 12). 
Flow cytometry and FACS. Single cell suspensions were generated from minced lung tissue that was subjected to 
collagenase (Liberase TM Research Grade, Roche), hyaluronidase (Sigma), DNAse I (Sigma), and Dispase II (Roche) 
digestion for 45 min at 37 °C and then treated with ACK buffer (Lonza) to remove red blood cells. Following FcR blockade, 
lung cell suspensions were incubated with labeled antibodies and were sorted using a Sony SY3200 Synergy high-speed cell 
sorter. The following antibodies were used: anti-mouse CD31 (clone MEC 13.3; BD Biosciences), anti-mouse CD45 (clone 
30-F11; BD Biosciences), anti-mouse EpCAM (clone G8.8; BioLegend), anti-mouse/human Itga6 (Clone GoH3; 
eBiosciences), anti-Aqp3 (Abcam) and anti-Ki-67 (clone SolA15, eBiosciences ). Anti-Aqp3 antibody is labeled by Zenon 
antibody labeling kit following the instruction of manufacturer (Molecular Probes). FACS results were plotted and analyzed 
using FlowJo software (TreeStar).  
Epithelial cell culture. For 3D-organoid cultures, epithelial cells from FACS were resuspended in SAGM (Lonza) mixed 
1:1 with growth-factor reduced Matrigel (BD Biosciences) and plated at 3 x 103 cells per 100 µL in 24-well Transwells 
(Corning). At first 5 days, SAGM was added with 10 µM Rock inhibitor (Sigma) but without FBS. After 5 d, SAGM was 
added with 10 % FBS but without Rock inhibitor. The medium was changes every two or three days. Spheres were cultured 
for 14 d for counting and were harvested from Matrigel using cell recovery solution (BD Biosciences) and embedded in OCT 
(Tissue-Tek) for frozen sectioning and immunostaining.  
scRNAseq analysis. CD31–CD45–EpCAM+ cells were isolated from mouse lungs at 12 and 21 after SeV infection or control 
PBS challenge, and cellular mRNA was purified and subjected to scRNAseq using the 10x Genomics platform. Next-
generation sequencing (NGS) data was processed with the Cell Ranger set of analysis pipelines (version 2.1.0, 
https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines) as follows: first, FASTQ files were 
generated for each sample by demultiplexing the sequencer’s base call files. Then, single-cell gene count matrices were 
generated by running “cellranger count” with mm10 transcript reference per sample, and all sample data was aggregated with 
“cellranger aggr”. In this process, sequence depth was normalized by subsampling reads from higher-depth data. The 
aggregated gene expression matrix contained 32,172 cells in total. Next, the gene expression matrix was processed with R 
package, Scater (1.6.3) (15). Before Scater normalization, we removed outlier cells with an extremely large or small number 
of UMI (UMI > 20000 or UMI < 500) or large mitochondria UMI ratio (> 0.2). Almost all cells (99.16%) passed these quality 
checks. We also removed genes with low average expression (mean UMI count < 0.01). Cell cycling scores were calculated 
for each cell using the cyclone algorithm in the R package Scran 1.6.9 (16). The gene expression matrix was then normalized 
with Scater that includes size-normalization and log transformation. Normalized gene expression matrix data was imported 
to R package Seurat 2.3.4 (17) without further normalization and was directly subjected to scaling and undesired variation 
removal wherein process data variations correlated with UMI count and percent of mitochondria were regressed out. All of 
the above analysis was performed in our high throughput computing facility in the Center for Genome Sciences and Systems 
Biology, Washington University in St. Louis. 
Additional data analysis for clustering, dimensional reduction, marker identification, and visualization was performed with 
Seurat. For dimensional reduction, principal component analysis (PCA) and t-Distributed Stochastic Neighbor Embedding 
(t-SNE) were performed. Genes with high variable expression were selected and used for PCA. The first 15 PCs were selected 
as important PCs based on the distribution of standard deviation for each PC. The 15 PCs were used for clustering and t-SNE. 
A shared nearest neighbor (SNN) modularity optimization-based clustering algorithm was used for clustering. The clusters 
were manually annotated by marker gene expression. Marker genes for each cluster were identified with the FindAllMarkers 
function in Seurat. 
Cell trajectory analysis was performed using partition-based graph abstraction (PAGA) for a pseudo-temporal ordering 
algorithm and RNA-velocity analysis of single cells based on spliced versus unspliced mRNA abundance. The partition-
based graph abstraction (PAGA) graph was constructed with the wild-type single cell dataset as described previously (18). 
Calculations were performed with Scanpy’s implementation. A series of data preprocessing for PAGA graph construction 
was performed according to Scanpy’s tutorial for PAGA analysis (https://scanpy-tutorials.readthedocs.io/en/latest/paga-
paul15.html). The force-directed graph was constructed and used for embedding the RNA velocity trajectory graph. 
Normalized gene expression matrix was imported into a Python package, Scanpy 1.4.0 (19). Force-directed graph (20) was 
constructed according to tutorials from Scanpy (https://scanpy.readthedocs.io/en/stable/tutorials.html.). RNA velocity was 
analyzed with Velocyto.py (version 0.17.17) (21) using the author instructions (http://velocyto.org/velocyto.py/). The files 
generated with the 10x Genomics Cell Ranger pipeline were used for RNA velocity analysis. First, Velocyto command line 
API was used to generate gene expression matrix of spliced UMI counts and unspliced UMI counts. The output file was saved 
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as a loom file per sample. All loom files were merged into a single file that was imported into Velocyto Python API to create 
the Velocyto object that was integrated with Force-directed graph and cluster label and then subjected to quality check and 
then filtered by the mRNA detection level (min_expr_counts=40, min_cells_express=30). After variable gene detection by a 
velocyto function, the UMI count of spliced and unspliced read were normalized by total molecule count. The velocyto object 
was subjected to a series of final data processing process; PCA, k-nn based imputation, velocity estimation, and shift 
calculation, and the vectors estimated by RNA velocity were projected on the Force-directed graph.  
scATACseq analysis. For data preprocessing for scATACseq analysis, NGS data was processed with the Cell Ranger ATAC 
pipelines (Cell Ranger ATAC version 1.0.0 from 10x Genomics) to generate bam files. Bam files were subjected to the 
preprocessing pipeline with Snap tools (version 1.2.6). Snap files were created for each sample condition according to the 
developer’s instructions as described at: https://support.10xgenomics.com/single-cell-atac/software/pipelines/latest/what-is-
cell-ranger-atac and https://github.com/r3fang/SnapATAC/wiki/FAQs#10X_snap, respectively). Downstream analysis was 
performed with SnapATAC (22) according to the instructions at 
https://github.com/r3fang/SnapATAC/blob/master/examples/10X_brain_5k/README.md). First, WT and Il33ko data were 
merged into a single data file. Outlier cells were removed if they had less than 2000 UMI. In addition, cells that had a large 
mitochondria UMI ratio (> 0.2) were removed. A total of 15988 cells passed these quality checks. Next, cell-bin matrix (CB 
matrix) was calculated at 5 kb resolution (bin.size = 5000).  The matrix was converted into a binary matrix (Bmat). Bmat was 
further converted into cell by gene matrix (Gmat) for all genes. For data analysis and visualization for scATACseq data, 
dimensionally reduction embeddings for diffusion map and t-SNE were calculated with Bmat (parameter: num.eigs=50). The 
cluster was identified by knn based Louvain clustering method (parameters: eigs.dims=1:20, k=15). For the cluster 
annotation, we used scRNAseq data. The Snap object was converted into the Seurat object and subjected to 
FindTransferAnchors, which is a data integration algorithm in Seurat. The inferred cluster name was manually modified by 
checking marker gene expression. Data visualization was performed with Seurat. For cell cycle phase calculation with 
scATACseq data, cell cycling scores were calculated for each cell with Scran (version 1.6.9). Instead of gene expression 
matrix, gene activity scores, which were stored as Gmat, was used cell cycling score calculation. For peak calling and 
differential peak identification, peak calling was done for all clusters with more than 100 cells with SnapATAC (22) and 
MACS2 (parameters: --nomodel --shift 100 --ext 200 --qval 5e-2 -B –SPMR). Peak information was saved as bed file per 
cluster and experimental condition. To find differentially accessible regions (DARs) between WT and Il33–/– samples, we 
used findDAR function in SnapATAC per each cluster (parameter: bcv=0.1). We analyzed DAR with p-value less than 0.05.  
In addition, Integrative Genomics Viewer (IGV) analysis was used to visualize each track for peak calling. For this analysis, 
we created tdf files containing normalized coverage data for each cluster in WT and Il33–/– samples using igvtools (version 
2.6.3) as described previously (23) with a user guide at: http://software.broadinstitute.org/software/igv/book/export/html/6. 
This normalization option multiplies each value by 1,000,000 / totalReadCount. Clusters with cell numbers less than 100 
were filtered out, resulting in 11 tdf files for WT and 10 tdf files for Il33–/– samples. These tdf files were then loaded into the 
IGV to analyze differentially accessible peaks in the mouse Il33 gene (preferences: normalize coverage data; genomic 
sequence: mm10 mouse). The four largest peaks (peak1: chr19:29,940,023-29,941,697; peak2: chr19:29,942,085-
29,943,373; peak3: chr19:29,945,522-29,947,192; peak4: chr19:29,947,506-29,949,400) within the mouse Il33 gene 
sequence were input to Toolkit for Cistrome Data Browser (Species: Mouse mm10; Data type in Cistrome: Transcription 
factor, chromatin regulator; Interval: the corresponding locus of ROI) to identify transcription factor binding sites as described 
previously (24, 25). BigWig format files (26) of the selected transcription factors were copied into IGV using WashU Browser 
(27) to match binding sites to Il33 reference sequences. 
Lung function testing. To assess lung function, we assessed blood oxygen saturation (SpO2) and airway reactivity to 
methacholine (MCh). For SpO2 monitoring, we used a MouseSTAT® pulse oximeter (Kent Scientific, Torrington, CT) 
applied to the paw skin under isoflurane anesthesia. To decrease variability in readings for this procedure, anesthetized mice 
were placed on the RightTemp warming pad, and the SpO2 reading was recorded when the Oxiwave signal was stable. For 
airway reactivity, we used our protocol for MCh nebulization to anesthetized mice and measurements for RRS using the 
FinePointe Resistance and Compliance system (Buxco Research Systems, Wilmington, NC) as described previously (9).   
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Supplemental Table 1. Antibodies for immunostaining. 
Target Protein Antibody Type Vendor Catalogue # 
Aqp3 Rabbit pAb1 Abcam ab125219 
Sftpc Rabbit pAb Abcam ab90716 
Pdpn Hamster mAb Abcam ab11936 
GFP Chicken pAb Abcam ab13970 
Muc5ac Mouse mAb (45M1), biotinylated Thermo Scientific MS-145-B 
Muc5ac Mouse mAb (45M1) Thermo Scientifc MS-145-P 
mCherry Mouse mAb Abcam ab125096 
Krt5 Rabbit pAb Abcam ab53121 
Scgba1 Goat pAb Santa Cruz Sc-9772 
Scgba1 Mouse pAb Santa Cruz Sc-130411 
Acetylated-α-tubulin Mouse mAb (6-11B-1) Sigma T6793 
Ki-67 Mouse mAb BD Pharmingen 550609 
Ki-67 Rabbit mAb Cell Signaling  12202 
Phospho-Cdk1 Rabbit mAb Abcam ab201008 
Cdk1 Rabbit pAb Abcam ab234345 
Active caspase-3 Rabbit mAb Cell Signaling 9664 
IL-33 Goat mAb R&D Systems AF3626 
F4/80 Rabbit mAb Cell Signaling 70076 
Cxcl17 Sheep pAb R&D Systems AF4270 
1Abbreviations: mAb, monoclonal antibody, pAb, polyclonal antibody.  
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Supplemental Table 2. Sequences of DNA primers and probes for real-time qPCR assays. 




























































































1Abbreviations: F, forward primer; R, reverse primer; P, MGB probe. 
2Primers and probes for all the genes were obtained from IDT, except for Trem2, which were from ABI that 
does not make sequences available.  
